NeoGenomics Laboratories
Fort Myers, FL, United States neogenomics.com From their website, Nov 2026
Work here? Claim this listing
About
NeoGenomics Laboratories provides oncology testing and information solutions for healthcare providers, biopharma partners, and patients. It offers disease-state testing, digital pathology, biomarker testing, and oncology data solutions from locations in the United States and the United Kingdom.
Services
Oncology solutions
Offers more than 500 oncology tests across major testing modalities for diagnosis, therapy guidance, prognosis, and clinical trial support.
PanTracer portfolio
Provides tissue and liquid biopsy comprehensive genomic profiling for solid tumors, including PanTracer Pro, PanTracer Tissue, PanTracer Tissue + HRD, and PanTracer LBx.
RaDaR ST MRD
Uses personalized circulating tumor DNA testing to detect molecular residual disease and recurrence in blood.
Digital pathology
Provides whole slide imaging and AI-enabled image analysis to support diagnosis and treatment decisions.
Biopharma partnerships
Supports pharma and biotech partners with multi-modal testing solutions, validated methodologies, and project support for drug development and clinical trials.
Oncology data solutions
Uses oncology data from patient profiles to support therapeutic discovery, clinical trial matching, and assessment of therapy outcomes.
Pathology solutions
Offers pathology testing services including immunohistochemistry, flow cytometry, and fluorescence in situ hybridization.
Specimen procurement services
Provides mobile phlebotomy and solid tissue block retrieval services.
- Turnaround
- 1 day to 10 days
- What to send
- Blood draw
- Solid tissue block
- FFPE
- Unstained slides
- Peripheral blood smear
Capabilities
- Assays and studies
- NGS
- Flow cytometry
- Single-gene molecular testing
- Immunohistochemistry (IHC)
- Digital pathology
- Fluorescence in situ hybridization (FISH)
6 more
- DNA-based next-generation sequencing (NGS)
- RNA-based next-generation sequencing (NGS)
- Comprehensive genomic profiling (CGP)
- Liquid biopsy
- Hematologic testing
- PCR
- Scale and capacity
- Over 500 tests
- Over 2 million patient profiles
- Over 40,000 unique providers
- 4,000 healthcare organizations
- 2,200 worldwide staff
- 7 locations across 2 continents
5 more
- More than 120 MDs and PhDs
- Over 1.7 million cancer-related tests each year
- More than 100,000 NGS tests each year
- About 4,400 medical sites
- More than 500,000 patients
- Therapeutic areas
- Oncology
- Lung cancer
- Breast cancer
- Colorectal cancer
- Gastric cancer
- Gynecologic cancer
4 more
- Hematologic cancer
- Myeloid disorders
- aNSCLC
- Ovarian cancer
Instruments and platforms
- Halo AP® platform
Modalities and species
- Modalities
- Solid tumor
- Hematologic cancer
- Liquid biopsy
- Tissue biopsy
- DNA sequencing
- RNA sequencing
4 more
- IHC
- FISH
- Flow cytometry
- ctDNA
- Species and models
- Human
- Cell lines
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 15189Self-reported
Scope: United Kingdom site
CLIASelf-reported
Scope: diagnostic laboratory services in California, Florida, Maryland, New York, Pennsylvania, and Rhode Island
CAPSelf-reported
Scope: selected sites listed on the certifications page
Company
- Type
- Testing lab
- Founded
- 1999
- Team
- 2,200 worldwide
- Quality
- CLIA (diagnostic laboratory services in California, Florida, Maryland, New York, Pennsylvania, and Rhode Island) · CAP (selected sites listed on the certifications page) · Medicare provider · Medicaid provider · HTA (United Kingdom site) · ISO 15189 (United Kingdom site)
Locations
- Address
- 9490 NeoGenomics Way Fort Myers, FL 33912
- Sites
- Aliso Viejo, United States
- Carlsbad, United States
- Ramsey, United States
- Durham, United States
- Houston, United States
- Cambridge, United Kingdom
- Serves
- United States, United Kingdom